Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Sanofi Reps' Morale Hits New Low as Layoff Rumors Circulate
- Sanofi-Aventis managers are driving their sales reps crazy with their refusal to either name a day on which layoffs will be announced or announce layoffs are not happening. With concrete information absent, rumors are taking their place. This person thinks the layoff count was determined five months ago. But this...
- Blog posts 2008-11-18
Additional Resources
- Sanofi CEO Viehbacher Wants More Cuts; Drug Reps' Necks on the Block
- Sanofi-Aventis's Q4 earnings call tomorrow could set the stage for a dramatic few days at the company, according to Bloomberg, as CEO Chris Viehbacher told analysts and his staff that Sanofi needs to cut operating costs and possibly buy a small or midsize firm. Viehbacher wants to get $1.3 billion...
- Blog posts 2009-02-10
- Sanofi Q4: No Nasty Surprises, But Viehbacher Is Focused on Sales Productivity Ratios
- There were no nasty surprises in Sanofi-Aventis's Q4 results. Yesterday, BNET had suggested that CEO Chris Viehbacher's desire to cut $1.3 billion in operating costs would fall upon sales reps, whose jobs would be axed. We also noted that, dollar for dollar (or euro for euro, in...
- Blog posts 2009-02-11
- Sanofi Layoffs Are a Lesson in How Not to Do It
- Sanofi-Aventis SNY could not have handled its recent round of layoffs in a worse way. It's like a case study in how not to do it. As a result, the process attracted negative attention to the company -- and heaped more indignity on those who lost their jobs -- that...
- Blog posts 2009-12-02
- Sanofi Names D-Day for Layoffs: Dec. 1
- UPDATE: Sanofi plans a similar layoff plan for Thanksgiving 2009. Sanofi-Aventis has named a day for announcing its layoffs: Dec. 1, a source tells BNET. The Dec. 1 date already came up on Café Pharma as a possible timeframe for the call....
- Blog posts 2008-11-24
- Several Hundred Sanofi Reps Get the Ax
- BNET readers were informed on Nov. 24 that there would be mass layoffs at Sanofi-Aventis on Dec. 1. Lo and behold -- it happened. The company says less than 10 percent of its sales force has been let go. The company employs 6,500 reps, so that's 650 or fewer. (BNET...
- Blog posts 2008-12-04
- New CEO Veihbacher, Plucked From the U.S., Could De-Frenchify Sanofi
- Paris-based pharma giant Sanofi-Aventis may be about to get a little less French with the appointment of Chris Viehbacher, formerly head of U.S. pharma at GlaxoSmithKline, as its new CEO. The company gets more than half of its revenues on its top drugs from the U.S. (as...
- Blog posts 2008-09-10
- Source: Sanofi Lays Off Contract Sales Reps, Great Valley R&D Staff
- Sanofi-Aventis SNY made phone calls to its contract drug sales reps to tell them whether they were keeping their jobs last week, a source tells BNET. It is not known how many contract reps got laid off. The company axed 750 staffers, mostly pharmaceutical sales reps, just after Thanksgiving. by...
- Blog posts 2009-12-13
- Sanofi Calls Hundreds of Reps With Layoff News
- Sanofi-Aventis SNY began calling hundreds of its drug sales reps today to tell them whether they were being laid off or keeping their jobs. A company spokesperson declined to comment when asked by BNET how many reps were affected. by Jim Edwards
- Blog posts 2009-11-30
- Pharma Roundup: Sanofi Axes Reps, Glaxo Fights Patent Office, and More
- Sanofi-Aventis cuts 650 sales reps, Glaxo heads to court, FDA deals Roche a setback, Deerfield may purchase all of Nitromed. by John Maas
- Blog posts 2008-12-04
- Sanofi Plans Layoffs on Nov. 30; Management Says "Happy Thanksgiving!"
- Sanofi-Aventis SNY has asked its drug sales reps to stay at home on Monday, Nov. 30, and await a phonecall that will tell them whether they have been laid of or not, a source tells BNET. Reps are annoyed that they received two messages from management this week: One telling...
- Blog posts 2009-11-25
- UPDATED: Sanofi's Cancer Division Next on the Chopping Block; 750 Jobs Gone This Week
- The cancer shoe has yet to drop at Sanofi-Aventis SNY, a source tells BNET, as the company lays off as many as 1,200 sales reps and other staff. Sales of Sanofi's Eloxatin cancer drug were decimated by generic competition this year, and the company is getting ready to ax many...
- Blog posts 2009-12-02
- The 10 Weirdest Drug Stories of the Month
- It's time again for BNET's roundup of the news that was too strange for our regular programming but too interesting to be ignored. Here are the 10 weirdest drug stories of November 2008: French Researchers Working Hard to Take the Fun Out of Pot In France,...
- Blog posts 2008-11-28
- Ranking of 20 Drug Companies' Sales Forces Shows Productivity Flat or Declining
- A ranking of drug company sales productivity shows Gilead gets the most revenues in return for every dollar invested in reps and marketing. At the other end of the table, Sepracor gets the least bang for its sales, general and administrative buck see table below. ...
- Blog posts 2009-02-24
- Insomnia Pill Makers Go After Elderly With New 'Fear of Falling'
- For years, drug companies have tried to expand the range of prescriptions of sleeping pills. They're not just for sleeping any more -- now they're also for avoiding "rebound insomnia" in the elderly, "increased risk of automotive crashes, decreased work performance ... or mood changes," generalized anxiety disorder, and depression....
- Blog posts 2008-09-11
- The GlaxoSmithKline-Allergan Deal Worst-Case Scenario
- Allergan's stock has risen on an item from DealReporter.com outlining acquisition discussions with GlaxoSmithKline. Allergan surged $5.41, or 13 percent, to $48.58, per Bloomberg, on the news. As usual, at BNET we ask: before the money gets spent, what's the worst-case scenario? The first...
- Blog posts 2009-03-25
- Kingsley & Kingsley, APC and Joseph & Herzfeld LLP Announces New Lawsuit Filed Against Sanofi -Aventis U.S. for Failure to Pay Pharmaceutical Reps Overtime
- Ten Major Drug Companies Now Face Class Action Suits for Violating Federal and State Labor Laws
- Research articles 2007-01-09
- Lilly Advertises "Effient" Despite Lack of FDA Approval
- Eli Lilly is advertising its new blood-thinner, Effient, even though it is not yet approved in the U.S. The drug also known as prasugrel is approved in Europe as "Efient," but ads in which the drug's name is spelled with two f's have appeared on the cardiologytoday.com web site. "Effient"...
- Blog posts 2009-02-25
- << Previous
- page 1 of 1
- Next >>
Presented by American Express